Skip to main content
. 2017 Dec 15;9(14):11441–11450. doi: 10.18632/oncotarget.23571

Table 2. Pathological features of patients with typical CD10-negative and CD10+ MCL.

CD10-negative MCL (n = 212) CD10+ MCL (n = 30) P Value
Morphologic type*
 Classic 80 (169/212) 40 (12/30)
 Blastoid/Pleomorphic 20 (43/212) 60 (18/30) < 0.0001
Immunohistochemistry
 Cyclin D1+* 100 (212/212) 97 (29/30) 0.12
 SOX11+* 69 (42/61) 63 (12/19) 0.78
 BCL6+* 7 (5/72) 31 (6/19) 0.009
 Medium Ki67 (%) 25 40
 Ki67 > 30%* 49 (66/135) 68 (17/25) 0.08
 Ki67 > 60%* 17 (23/135) 32 (8/25) 0.09

* = %(positive/evaluated)